MiNK Therapeutics Reports Corporate Update and Second Quarter 2022 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. SPY
9. IVBIY
10. FIX

Go back to MiNK Therapeutics Reports Corporate Update and Second Quarter 2022 Financial Results

MiNK Therapeutics, Inc. (INKT) Tops Q2 EPS by 5c

August 9, 2022 8:13 AM EDT

MiNK Therapeutics, Inc. (NASDAQ: INKT) reported Q2 EPS of ($0.18), $0.05 better than the analyst estimate of ($0.23).

For earnings history and earnings-related data on MiNK Therapeutics, Inc. (INKT) click here.

... More